CNR1 and Alzheimer disease: In Alzheimer’s disease (AD), for instance, activation of CB2 on the microglia has the effect of upregulating the amyloid-β clearance systems and redirecting the microglia to the phagocytic, anti-inflammatory phenotype, while CB1 leads to a reduction in glutamate excitotoxicity and sustenance of synaptic plasticity [209].